Order Article Reprints

Jaskula E, Dlubek D, Tarnowska A, Lange J, Mordak-Domagala M, Suchnicki K, Sedzimirska M, Borowik A, Mizia S, Lange A. Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes. Viruses. 2015; 7(3):1391-1408. https://doi.org/10.3390/v7031391

Jaskula, Emilia, Dorota Dlubek, Agnieszka Tarnowska, Janusz Lange, Monika Mordak-Domagala, Krzysztof Suchnicki, Mariola Sedzimirska, Agata Borowik, Sylwia Mizia, and Andrzej Lange. 2015. "Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes" Viruses 7, no. 3: 1391-1408. https://doi.org/10.3390/v7031391

Jaskula, E., Dlubek, D., Tarnowska, A., Lange, J., Mordak-Domagala, M., Suchnicki, K., Sedzimirska, M., Borowik, A., Mizia, S., & Lange, A. (2015). Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes. Viruses, 7(3), 1391-1408. https://doi.org/10.3390/v7031391